Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ammuxetine

An alternative spelling of ammoxetine, an investigational antidepressant from China that inhibits the reuptake of serotonin and noradrenaline. In 2025 the results of a phase 2 trial in adults with major depression were published. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.

Did you know?It derives from duloxetine: researchers replaced its naphthalene ring with a benzodioxole ring, a change designed to reduce toxicity to the liver.

AmmuxetineGo to the active ingredient →
AmmuxetineActive ingredientAmmuxetineCat. No. P-A138-001CAS 1202707-24-1

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.